tirzepatide en polvo Mounjaro® (tirzepatide) injection and Zepbound®

GLP-1 Medications First created to treat Type 2 diabetes, GLP-1 medications, including Ozempic, Mounjaro, Wegovy, Zepbound, Trulicity, Rybelsus and others, have grown significantly in popularity after they became linked with significant weight loss and beneficial metabolic effects

Development and characterization of new topical hydrogels based on alpha lipoic acid-hydrotalcite hybrids

Weight-loss drugs among the GLP-1 class are largely driving the increase in prescriptions and spending, according to the Health Policy Commission

Studies demonstrate that ipamorelin-induced increases in growth hormone and IGF-1 levels can help counteract these age-related changes

While FDA-approved semaglutide medications like Wegovy and Ozempic are widely used for weight loss and diabetes management, compounded versions offer a personalized approach that can be more cost-effective